My Healthcare News & Research — March 13, 2026

Special Deep Dive: Creatine — From Gym Supplement to Medical Breakthrough

For decades, creatine monohydrate was pigeonholed as a bodybuilder's supplement — something you kept next to the protein powder and never thought twice about. That era is over. A convergence of landmark clinical trials, revolutionary neuroscience discoveries, and paradigm-shifting immunology research has transformed creatine into one of the most important compounds in modern medicine. In this special deep dive, we examine the research that is redefining what creatine can do for the human body — from the brain to the immune system to the aging cell.

Table of Contents

685 Clinical Trials, Zero Harmful Side Effects

Let us begin with the headline that should end the safety debate permanently. In 2025, Dr. Richard B. Kreider and colleagues at Texas A&M University published a comprehensive analysis of 685 clinical trials involving creatine supplementation in the Journal of the International Society of Sports Nutrition. Their conclusion was unambiguous: there were no significant differences in the rate of side effects between creatine and placebo groups across the entire body of clinical evidence.

Kreider, who has authored over 300 peer-reviewed articles on creatine with more than 27,800 citations (h-index 78), has been at the forefront of creatine research for three decades. He was the lead author of the International Society of Sports Nutrition's official position stands on creatine in both 2007 and 2017, the latter of which stated: "Short- and long-term supplementation (up to 30 g/day for 5 years) is safe and well-tolerated in healthy individuals and in patient populations ranging from infants to the elderly."

The 2025 analysis is the most comprehensive safety evaluation of any dietary supplement ever conducted. It spans populations from premature infants with creatine deficiency syndromes to elderly heart failure patients, from elite athletes to sedentary adults with neurological disease. No supplement in the history of nutritional science has been tested as rigorously or vindicated as thoroughly.

Creatine as a Neurotransmitter: The Discovery That Stunned Neuroscience

In 2023, Dr. Yi Rao at Peking University published a paper in eLife that may fundamentally reshape our understanding of brain chemistry. Using a combination of chemical analysis, biochemistry, and electrophysiology, Rao's team presented evidence that creatine is not merely an energy substrate in the brain but may function as a genuine neurotransmitter in the central nervous system.

The evidence is striking. Creatine was found to be present in synaptic vesicles — the tiny membrane-bound packets that store neurotransmitters at nerve terminals — at concentrations higher than acetylcholine and serotonin, though lower than the major neurotransmitters glutamate and GABA. Electrophysiological recordings demonstrated that creatine inhibits a fraction of pyramidal neurons in the neocortex, consistent with a role as an inhibitory neurotransmitter.

No molecularly defined creatine receptor has yet been identified, and the finding remains to be replicated by independent groups. But if confirmed, the implications are profound. It would mean that creatine supplementation is not just fueling the brain's energy demands but directly modulating neural signaling. A follow-up paper in Frontiers in Nutrition (2025) has already begun exploring a "muscle-brain axis" framework for understanding creatine's cognitive effects, and the U.S. Department of Defense published an information paper on creatine and traumatic brain injury neuroprotection, reflecting growing military interest in creatine's neurological potential.

First-Ever Alzheimer's Trial Shows Brain Creatine Can Be Restored

The CABA trial, conducted at the University of Kansas Medical Center and published in Alzheimer's & Dementia: Translational Research & Clinical Interventions (2025), represents a milestone in both creatine and Alzheimer's disease research. It is the first randomized clinical trial to test creatine supplementation in patients with Alzheimer's disease.

Twenty patients received 20 g/day of creatine monohydrate for 8 weeks. The results demonstrated three key findings:

  1. Brain creatine levels increased measurably, confirming that oral creatine supplementation can cross the blood-brain barrier and raise cerebral creatine stores even in Alzheimer's patients.
  2. Moderate improvements in working memory and executive function were observed, though the study was not powered to detect large clinical effects.
  3. Muscle strength and lean mass also improved, addressing the sarcopenia and physical frailty that commonly accompany Alzheimer's disease.

The CABA trial is a proof-of-concept study. A Phase III trial with larger enrollment and longer follow-up is in planning. But the fundamental finding — that we can restore creatine to depleted Alzheimer's brains via a safe, inexpensive, orally available supplement — opens an entirely new therapeutic avenue. Alzheimer's disease is characterized by profound cerebral energy failure, and creatine is the most direct way to address it.

Single-Dose Creatine Rescues the Sleep-Deprived Brain

The relationship between creatine and cognitive performance under stress has been studied since Dr. Terry McMorris at the University of Chichester demonstrated in 2006 (Psychopharmacology) and 2007 (Physiology & Behavior) that creatine loading (20 g/day for 7 days) protected cognitive function during 24- and 36-hour sleep deprivation. But a 2024 study pushed the frontier even further.

Gordji-Nejad et al. (2024), published in Scientific Reports, became the first study to demonstrate that a single acute dose of creatine can alter cerebral high-energy phosphate metabolism and improve cognition during sleep deprivation. Using phosphorus-31 magnetic resonance spectroscopy (31P-MRS), the researchers observed real-time changes in brain PCr/Pi ratios, ATP levels, and intracellular pH following a single high dose of creatine. Processing speed improved significantly.

This finding has immediate practical implications for shift workers, medical residents, military personnel, new parents, and anyone facing acute sleep deprivation. Unlike caffeine, which masks fatigue signals without restoring brain energy, creatine appears to actually replenish the brain's depleted energy reserves. The earlier loading studies by McMorris showed that pre-loaded creatine could preserve choice reaction time, balance, and mood after an entire night without sleep — effects that caffeine alone cannot match for higher-order cognitive tasks.

Creatine Doubles the Speed of Antidepressant Response in Women

Major depressive disorder remains one of the most prevalent and disabling conditions worldwide, and one of the cruelest aspects of current pharmacotherapy is the 4-8 week delay before antidepressants take full effect. During this lag period, patients remain symptomatic and at elevated risk. A 2012 trial by Dr. In Kyoon Lyoo at Seoul National University suggested that creatine may solve this problem.

Published in the American Journal of Psychiatry, the study enrolled 52 women with MDD who received the SSRI escitalopram plus either creatine (5 g/day) or placebo for 8 weeks. The creatine group showed significantly greater improvement beginning at week 2, with an odds ratio of 11.68 for treatment response compared to placebo. By week 8, the odds ratio was 6.92 — still nearly seven times more likely to respond.

The mechanistic explanation came from brain imaging. Phosphorus-31 MRS revealed that increased cerebral phosphocreatine levels correlated directly with symptom improvement in the creatine group. Depression involves measurable cerebral energy deficits, and creatine appears to restore the bioenergetic capacity the brain needs to respond to serotonergic medication. Subsequent pilot studies have explored creatine combined with 5-HTP for treatment-resistant depression, with encouraging preliminary results.

Protecting the Injured Brain: Creatine and Traumatic Brain Injury

Traumatic brain injury (TBI) triggers a devastating cascade of energy failure, excitotoxicity, oxidative stress, and mitochondrial dysfunction. The phosphocreatine system is the brain's first line of defense against energy crisis, and augmenting it before or after injury holds therapeutic promise.

Dr. Georgios Sakellaris in Greece conducted the only pediatric clinical trials of creatine for TBI, with remarkable results. In a 2006 open-label randomized pilot study published in the Journal of Trauma, 39 children aged 1-18 with TBI received creatine 0.4 g/kg/day for 6 months. The creatine group showed significant improvements in cognition (p < 0.001), personality and behavior (p < 0.001), self-care (p = 0.029), and communication (p = 0.018), with no side effects. A 2008 follow-up in Acta Paediatrica showed significant reductions in headache, dizziness, and fatigue.

Animal models demonstrate that creatine administered before injury provides the strongest neuroprotection, reducing cortical damage by 36% in mice and 50% in rats. This has prompted a paradigm shift in thinking: rather than waiting to treat TBI after it occurs, pre-loading creatine in at-risk populations — contact sport athletes, military personnel, construction workers — could provide a prophylactic neuroprotective buffer. The U.S. Department of Defense published an information paper on creatine and TBI in 2025, and a new randomized controlled trial for mild TBI is registered on ClinicalTrials.gov (NCT06644131).

Creatine Powers Killer T Cells: A New Weapon Against Cancer

Perhaps the most surprising chapter in creatine's evolving story comes from cancer immunology. In 2019, Dr. Lili Yang at UCLA published a landmark study in the Journal of Experimental Medicine demonstrating that creatine functions as a "molecular battery" for CD8 T cells — the immune system's primary cancer-killing cells.

Yang's team showed that T cells require enormous amounts of energy to sustain their anti-tumor activity, and the creatine-phosphocreatine system is critical for meeting this demand. T cells engineered to lack the creatine transporter gene (CrT/Slc6a8) had severely impaired ability to kill cancer cells. The breakthrough finding: oral creatine supplementation at doses comparable to those used by human athletes suppressed both skin and colon cancer tumor growth in mice. When combined with PD-1/PD-L1 checkpoint inhibitor immunotherapy — one of the most important cancer treatments developed in the past decade — creatine produced synergistic tumor suppression.

A 2023 study in Frontiers in Immunology extended these findings to macrophages, showing that creatine supplementation enhanced anti-tumor immunity by promoting ATP production in tumor-associated macrophages, increasing their frequency and number within tumors. Epidemiological data from NHANES 2007-2018, published in Frontiers in Nutrition (2024), found that higher dietary creatine intake was associated with approximately a 1% reduction in cancer risk for every additional milligram per kilogram of body mass consumed daily.

A double-blind randomized controlled trial (CREATINE-52), registered in BMC Cancer (2024), is now examining whether creatine supplementation can preserve muscle mass and attenuate cancer progression in patients. We may be witnessing the emergence of creatine as an adjunct to immunotherapy — a safe, cheap, widely available compound that helps the immune system fight cancer more effectively.

HbA1c Drops a Full Point: Creatine in Type 2 Diabetes

Dr. Bruno Gualano at the University of São Paulo, Brazil, conducted the most compelling study on creatine and type 2 diabetes to date. Published in Medicine & Science in Sports & Exercise (2011), this 12-week randomized, double-blind, placebo-controlled trial enrolled 25 type 2 diabetic patients.

The results were dramatic. The creatine group (5 g/day combined with exercise training) saw HbA1c decrease from 7.4% to 6.4% — a full percentage point drop — compared to 7.5% to 7.6% in the placebo group (p = 0.004). To put this in context, a 1% reduction in HbA1c is associated with a 37% reduction in microvascular complications and a 21% reduction in diabetes-related death. The creatine group also showed decreased glycemia during a meal tolerance test and, crucially, increased GLUT-4 translocation to the cell surface — the molecular mechanism by which glucose enters muscle cells.

The proposed mechanisms include enhanced AMPK-alpha activation (the same energy-sensing pathway activated by the diabetes drug metformin), increased beta-cell insulin secretion, and improved cellular water retention triggering osmosensing gene expression. While larger confirmatory trials are needed, the magnitude of the HbA1c reduction — achieved with a supplement that costs pennies per day — warrants serious attention from the diabetes research community.

The Menopause Brain Fog Solution? CONCRET-MENOPA Trial Results

Cognitive complaints during perimenopause and menopause — commonly described as "brain fog" — affect up to 60% of women during the menopausal transition and are driven in part by declining estrogen's effects on cerebral energy metabolism. The CONCRET-MENOPA trial (2026), published in the Journal of the American Nutrition Association, asked whether creatine could fill this energy gap.

Thirty-six perimenopausal and menopausal women were randomized to low-dose creatine HCl (750 mg/day), medium-dose creatine HCl (1,500 mg/day), a combination of creatine HCl and creatine ethyl ester (800 mg/day), or placebo for 8 weeks. The results exceeded expectations:

These results are particularly notable because the doses used (750-1,500 mg/day) are far lower than the standard 3-5 g/day used in athletic supplementation, suggesting that even modest creatine intake may meaningfully benefit brain function during the menopausal transition. Given that females have 70-80% lower endogenous creatine stores than males, the therapeutic window for creatine supplementation in women may be broader than previously appreciated.

Creatine as an Anti-Aging Compound: Cellular Senescence and Beyond

Aging is driven by a constellation of interconnected cellular processes: mitochondrial dysfunction, oxidative stress accumulation, telomere attrition, genomic instability, chronic low-grade inflammation, and cellular senescence (the permanent arrest of cell division). Emerging research suggests creatine may influence multiple hallmarks of aging simultaneously.

A 2025 review in the Journal of the International Society of Sports Nutrition outlined the case for creatine as an adjunct to healthy aging, emphasizing its ability to preserve muscle mass (combating sarcopenia), support bone health, and enhance cognitive function in aging populations. The same year, a paper in Experimental Gerontology titled "Creatine and cellular senescence: from molecular pathways to populational health" described specific mechanisms through which creatine may slow biological aging.

The meta-analysis by Chilibeck, Kaviani, Candow, and Zello (2017) in the Open Access Journal of Sports Medicine provided the clinical evidence: creatine combined with resistance training in older adults increased lean tissue mass and both upper and lower body strength significantly more than resistance training alone. The combination of preserved muscle mass, enhanced cellular energy, improved cognitive function, and potential bone health benefits positions creatine as one of the few compounds that addresses aging across multiple organ systems simultaneously.

The Kidney Myth: How a Misread Lab Test Became Medical Folklore

No discussion of creatine is complete without addressing the most persistent myth in sports nutrition: the belief that creatine damages the kidneys. This myth has caused millions of people to avoid a supplement with an extraordinary safety record, and it arose from a simple misunderstanding of laboratory chemistry.

Creatine is naturally broken down in the body to creatinine, which is excreted by the kidneys. Serum creatinine is used in clinical medicine as a surrogate marker for kidney function — when the kidneys fail, creatinine accumulates in the blood. When someone takes supplemental creatine, more creatinine is produced as a normal metabolic byproduct, causing serum creatinine to rise. A clinician unfamiliar with the patient's supplementation status may interpret this as kidney damage. It is not. It is simply more substrate producing more product.

Dr. Jacques Poortmans at the Free University of Brussels published the definitive renal safety studies. In 1999, he compared kidney function in national and international athletes using creatine (at doses up to 80 g/day for up to 60 months) with non-users and found no significant differences in any marker of renal function. A 2005 follow-up confirmed no signs of renal impairment at 21 g/day for 14 days. A 2025 systematic review and meta-analysis in BMC Nephrology confirmed that creatine supplementation causes no significant changes in GFR (glomerular filtration rate), the gold standard measure of kidney function.

The 2017 ISSN position stand stated it plainly: "No scientific evidence supports that short- or long-term supplementation with creatine monohydrate causes any harmful side effects." The 2025 analysis of 685 trials confirmed it definitively. It is time for the medical community to update its understanding and stop discouraging patients from using one of the safest and most beneficial supplements ever studied.

Who Benefits Most? Vegetarians, Women, and the Elderly

While creatine benefits virtually everyone, three populations show particularly large responses:

Vegetarians and Vegans

Because dietary creatine comes almost exclusively from meat and fish, vegetarians average approximately 100 mmol/kg of dry muscle creatine vs. 120 mmol/kg in omnivores. Brain creatine is also lower. Benton and Donohoe (2011) in the British Journal of Nutrition showed that creatine supplementation improved memory in vegetarians but not omnivores, while Caroline Rae's landmark 2003 cognitive study specifically recruited vegetarians to exploit this greater response potential. For the estimated 1.5 billion vegetarians worldwide, creatine supplementation may be one of the most impactful nutritional interventions available.

Women

Females have 70-80% lower endogenous creatine stores than males. Smith-Ryan et al. (2021) in Nutrients reviewed evidence across the female lifespan and found particular potential for women in strength, mood, cognition, and reproductive health. The CONCRET-MENOPA trial demonstrated measurable brain benefits at doses as low as 750 mg/day. NHANES data (Ostojic et al., 2024) linked higher dietary creatine with lower risk of several gynecological conditions. Animal research at Monash University suggests maternal creatine supplementation during pregnancy could provide fetal neuroprotection during birth complications.

Older Adults

The combination of declining muscle mass, reduced brain energy metabolism, and increased vulnerability to falls, fractures, and cognitive decline makes older adults ideal candidates for creatine supplementation. The Chilibeck meta-analysis (2017) confirmed benefits for lean mass and strength, while a 2024 meta-analysis found working memory and executive function improved most consistently with creatine in older adults. Darren Candow's 2-year trial in 237 postmenopausal women showed preservation of bone structural integrity alongside increased lean mass.

Full Reference List

Foundational Studies

  1. Harris RC, Söderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clinical Science. 1992;83(3):367-374. PubMed
  2. Hultman E, Söderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. Journal of Applied Physiology. 1996;81(1):232-237. PubMed
  3. Volek JS, et al. Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Medicine & Science in Sports & Exercise. 1999;31(8):1147-1156. PubMed

Safety and Position Stands

  1. Poortmans JR, Francaux M. Long-term oral creatine supplementation does not impair renal function in healthy athletes. Medicine & Science in Sports & Exercise. 1999;31(8):1108-1110. PubMed
  2. Kreider RB, et al. Long-term creatine supplementation does not significantly affect clinical markers of health in athletes. Molecular and Cellular Biochemistry. 2003;244(1-2):95-104. PubMed
  3. Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation. JISSN. 2017;14:18. PubMed
  4. Kreider RB, et al. Comprehensive analysis of 685 clinical trials. JISSN. 2025. PMC
  5. Creatine supplementation and renal function: systematic review and meta-analysis. BMC Nephrology. 2025. PMC

Brain and Cognition

  1. Rae C, Digney AL, McEwan SR, Bates TC. Oral creatine monohydrate supplementation improves brain performance. Proceedings of the Royal Society B. 2003;270(1529):2147-2150. PubMed
  2. Watanabe A, Kato N, Kato T. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neuroscience Research. 2002;42(4):279-285.
  3. McMorris T, et al. Effect of creatine supplementation and sleep deprivation on cognitive psychomotor performance. Psychopharmacology. 2006;185(1):93-103. PubMed
  4. McMorris T, et al. Effect of creatine supplementation and sleep deprivation with mild exercise on cognitive and psychomotor performance. Physiology & Behavior. 2007;91(2-3):271-278.
  5. Rao Y, et al. Suggestion of creatine as a new neurotransmitter. eLife. 2023;12:e89317. eLife
  6. Gordji-Nejad A, et al. Single dose creatine improves cognitive performance during sleep deprivation. Scientific Reports. 2024;14:4937. Nature
  7. Xu Y, et al. Creatine supplementation and cognitive function: systematic review and meta-analysis. Frontiers in Nutrition. 2024. Frontiers
  8. Smith CD, et al. CABA pilot trial: creatine in Alzheimer's disease. Alzheimer's & Dementia: TRC&I. 2025. Wiley

Depression and Mental Health

  1. Lyoo IK, Yoon S, Kim TS, et al. Creatine augmentation for enhanced SSRI response in women with MDD. American Journal of Psychiatry. 2012;169(9):937-945. PMC

Traumatic Brain Injury

  1. Sakellaris G, et al. Prevention of TBI complications in children with creatine administration. Journal of Trauma. 2006;61(2):322-329. PubMed
  2. Sakellaris G, et al. Creatine administration and TBI outcomes. Acta Paediatrica. 2008.

Cancer and Immunology

  1. Yang L, et al. Creatine uptake regulates CD8 T cell antitumor immunity. Journal of Experimental Medicine. 2019;216(12):2869-2882. JEM
  2. Creatine enhances anti-tumor immunity via macrophage ATP production. Frontiers in Immunology. 2023. Frontiers
  3. Dietary creatine intake and cancer risk: NHANES 2007-2018. Frontiers in Nutrition. 2024. Frontiers
  4. CREATINE-52 trial protocol. BMC Cancer. 2024. Springer

Diabetes

  1. Gualano B, et al. Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Medicine & Science in Sports & Exercise. 2011;43(5):770-778. PubMed

Women's Health and Menopause

  1. Smith-Ryan AE, et al. Creatine supplementation in women's health: a lifespan perspective. Nutrients. 2021;13(3):877. MDPI
  2. Ostojic SM, et al. Dietary creatine and female reproductive health. Food Science & Nutrition. 2024. Wiley
  3. CONCRET-MENOPA trial: creatine and menopause cognition. Journal of the American Nutrition Association. 2026. PubMed

Aging and Sarcopenia

  1. Chilibeck PD, Kaviani M, Candow DG, Zello GA. Creatine supplementation in older adults. Open Access Journal of Sports Medicine. 2017;8:213-226. PMC
  2. Rawson ES, Volek JS. Effects of creatine and resistance training on strength. JSCR. 2003;17(4):822-831. PubMed
  3. Delpino FM, et al. Creatine supplementation and lean body mass: meta-analysis. Nutrition. 2022;103-104:111791.

Bone Health

  1. Candow DG, et al. Creatine supplementation for postmenopausal bone health: 2-year RCT. Medicine & Science in Sports & Exercise. 2023;55(10):1750-1761. PMC

Cardiovascular

  1. Gordon A, et al. Creatine supplementation in chronic heart failure. European Heart Journal. 1995;16(4):533-540. PubMed
  2. Andrews R, et al. Creatine in congestive heart failure. European Heart Journal. 1998;19(4):617-622. OUP

Vegetarians

  1. Benton D, Donohoe R. The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores. British Journal of Nutrition. 2011;105(7):1100-1105. Cambridge

Creatine Deficiency Syndromes

  1. Stockler-Ipsiroglu S, et al. GAMT deficiency: outcomes in 48 individuals. Molecular Genetics and Metabolism. 2014. GeneReviews